These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 17643576)

  • 41. Beta-blocker use and outcomes among hospitalized heart failure patients.
    Butler J; Young JB; Abraham WT; Bourge RC; Adams KF; Clare R; O'Connor C;
    J Am Coll Cardiol; 2006 Jun; 47(12):2462-9. PubMed ID: 16781374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients.
    Owan TE; Hodge DO; Herges RM; Jacobsen SJ; Roger VL; Redfield MM
    J Card Fail; 2006 May; 12(4):257-62. PubMed ID: 16679257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure.
    Gustafsson I; Brendorp B; Seibaek M; Burchardt H; Hildebrandt P; Køber L; Torp-Pedersen C;
    J Am Coll Cardiol; 2004 Mar; 43(5):771-7. PubMed ID: 14998615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failure.
    Kociol RD; Greiner MA; Hammill BG; Phatak H; Fonarow GC; Curtis LH; Hernandez AF
    Am J Cardiol; 2010 Jun; 105(12):1786-93. PubMed ID: 20538131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure.
    Horwich TB; Hernandez AF; Dai D; Yancy CW; Fonarow GC
    Am Heart J; 2008 Dec; 156(6):1170-6. PubMed ID: 19033015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure.
    Rodríguez-Artalejo F; Guallar-Castillón P; Pascual CR; Otero CM; Montes AO; García AN; Conthe P; Chiva MO; Banegas JR; Herrera MC
    Arch Intern Med; 2005 Jun; 165(11):1274-9. PubMed ID: 15956007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction.
    Deswal A; Bozkurt B
    Am J Cardiol; 2006 Apr; 97(8):1228-31. PubMed ID: 16616031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of mortality and hospitalization for cardiac causes in patients with heart failure and nonischemic heart disease: a subanalysis of the ALPHA study.
    Anselmino M; De Ferrari GM; Massa R; Manca L; Tritto M; Molon G; Curnis A; Devecchi P; Sarzi Braga S; Bartesaghi G; Klersy C; Accardi F; Salerno-Uriarte JA;
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S214-8. PubMed ID: 19250099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program.
    Blair JE; Zannad F; Konstam MA; Cook T; Traver B; Burnett JC; Grinfeld L; Krasa H; Maggioni AP; Orlandi C; Swedberg K; Udelson JE; Zimmer C; Gheorghiade M;
    J Am Coll Cardiol; 2008 Nov; 52(20):1640-8. PubMed ID: 18992654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients.
    Butler J; Forman DE; Abraham WT; Gottlieb SS; Loh E; Massie BM; O'Connor CM; Rich MW; Stevenson LW; Wang Y; Young JB; Krumholz HM
    Am Heart J; 2004 Feb; 147(2):331-8. PubMed ID: 14760333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated admission glucose and mortality in elderly patients hospitalized with heart failure.
    Kosiborod M; Inzucchi SE; Spertus JA; Wang Y; Masoudi FA; Havranek EP; Krumholz HM
    Circulation; 2009 Apr; 119(14):1899-907. PubMed ID: 19332465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of hospital length of stay for heart failure on quality of care.
    Krantz MJ; Tanner J; Horwich TB; Yancy C; Albert NM; Hernandez AF; Dai D; Fonarow GC;
    Am J Cardiol; 2008 Dec; 102(12):1693-7. PubMed ID: 19064026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry.
    Klapholz M; Maurer M; Lowe AM; Messineo F; Meisner JS; Mitchell J; Kalman J; Phillips RA; Steingart R; Brown EJ; Berkowitz R; Moskowitz R; Soni A; Mancini D; Bijou R; Sehhat K; Varshneya N; Kukin M; Katz SD; Sleeper LA; Le Jemtel TH;
    J Am Coll Cardiol; 2004 Apr; 43(8):1432-8. PubMed ID: 15093880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
    Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
    J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The importance of consistent, high-quality acute myocardial infarction and heart failure care results from the American Heart Association's Get with the Guidelines Program.
    Wang TY; Dai D; Hernandez AF; Bhatt DL; Heidenreich PA; Fonarow GC; Peterson ED
    J Am Coll Cardiol; 2011 Aug; 58(6):637-44. PubMed ID: 21798428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).
    Greene SJ; Vaduganathan M; Lupi L; Ambrosy AP; Mentz RJ; Konstam MA; Nodari S; Subacius HP; Fonarow GC; Bonow RO; Gheorghiade M;
    Am J Cardiol; 2013 Feb; 111(4):574-81. PubMed ID: 23206923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada.
    Ko DT; Tu JV; Masoudi FA; Wang Y; Havranek EP; Rathore SS; Newman AM; Donovan LR; Lee DS; Foody JM; Krumholz HM
    Arch Intern Med; 2005 Nov; 165(21):2486-92. PubMed ID: 16314545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program.
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2008 Jul; 52(3):190-9. PubMed ID: 18617067
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE).
    Fonarow GC; Heywood JT; Heidenreich PA; Lopatin M; Yancy CW;
    Am Heart J; 2007 Jun; 153(6):1021-8. PubMed ID: 17540205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.